Biologics Research Review, Issue 2

In this Issue:

Skin lesions associated with anti-TNF for IBD
Secukinumab for ankylosing spondylitis
Dupilumab for moderate-to-severe atopic dermatitis
Consensus decision models for biologics in RA and PsA
Siltuximab for multicentric Castleman disease
Response to golimumab in UC
Biologics and cardiovascular risk in older RA patients
Anti-TNF-α treatment persistence in immune-mediated rheumatic disease

Please login below to download this issue (PDF)

Subscribe